BIPIX Stock: ProFunds Biotechnology UltraSector Fund Investor Class Stock Price, Analysis & Insights
Get live BIPIX stock price $70.93, comprehensive ProFunds Biotechnology UltraSector Fund Investor Class stock analysis, charts, news, and expert forecast. Real-time BIPIX stock data and investment insights.
Loading chart data...
ProFunds Biotechnology UltraSector Fund Investor Class (BIPIX) Overview
ProFunds Biotechnology UltraSector Fund Investor Class (BIPIX) is a publicly traded company in the Financial Services sector , specifically within the Asset Management industry . As of the latest trading session, BIPIX trades at $70.93 with a market capitalization of 276.36M . Over the past 52 weeks, BIPIX has traded between $38.23 and $80.00 , with the current price positioned at approximately...
Key Takeaways
- Operates in the Financial Services sector (Asset Management)
- Market cap: 276.36M
- Current price: $70.93
- 52-week range: $38.23 - $80.00
- P/E ratio: 2.74
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
This fund's primary objective is to generate daily investment returns that are one and a half times (1.5x) the daily movement of the Dow Jones U.S. BiotechnologySM Index, before any deductions for fees and expenses. To achieve this leveraged daily ex...
Company Information
- CEO
- Sector
- Financial Services
- Industry
- Asset Management
- Employees
- N/A
Contact Information
- Address
- 7272 Wisconsin Avenue
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Financial Services sector with established market position
✓ Listed on major US exchange (NASDAQ) providing liquidity and transparency
✓ Valuation metrics suggest potential value opportunity (P/E: 2.7)
✓ Higher growth potential with elevated volatility (Beta: 1.62)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for ProFunds Biotechnology UltraSector Fund Investor Class shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Financial Services may affect company performance
- ⚠Past performance does not guarantee future results for ProFunds Biotechnology UltraSector Fund Investor Class
- ⚠Investors should consider how ProFunds Biotechnology UltraSector Fund Investor Class fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
276.36M
P/E Ratio (TTM)
2.74
Beta
1.62
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare BIPIX with peer companies:
- Price
- $36.61
- Market cap
- 142.64M
- Price
- $11.27
- Market cap
- 244.48M
- Price
- $18.40
- Market cap
- 289.94M
- Price
- $17.73
- Market cap
- 293.38M
- Price
- $12.34
- Market cap
- 246.96M
- Price
- $57.68
- Market cap
- 185.19M
- Price
- $6.30
- Market cap
- 197.73M
- Price
- $11.48
- Market cap
- 254.21M
- Price
- $17.82
- Market cap
- 243.38M
- Price
- $17.66
- Market cap
- 242.56M
About Financial Services Sector
The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.

